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Structural and Dynamic Features
of F-recruitment Site Driven
Substrate Phosphorylation by
ERK2
Andrea Piserchio1,*, Venkatesh Ramakrishan1,*, Hsin Wang1, Tamer S. Kaoud2,3,
Boris Arshava4, Kaushik Dutta5, Kevin N. Dalby2 & Ranajeet Ghose1,6,*
The F-recruitment site (FRS) of active ERK2 binds F-site (Phe-x-Phe-Pro) sequences found
downstream of the Ser/Thr phospho-acceptor on cellular substrates. Here we apply NMR methods
to analyze the interaction between active ERK2 (ppERK2), and a 13-residue F-site-bearing peptide
substrate derived from its cellular target, the transcription factor Elk-1. Our results provide detailed
insight into previously elusive structural and dynamic features of FRS/F-site interactions and FRSdriven substrate phosphorylation. We show that substrate F-site engagement significantly quenches
slow dynamics involving the ppERK2 activation-loop and the FRS. We also demonstrate that the
F-site phenylalanines make critical contacts with ppERK2, in contrast to the proline whose cis-trans
isomerization has no significant effect on F-site recognition by the kinase FRS. Our results support a
mechanism where phosphorylation of the disordered N-terminal phospho-acceptor is facilitated by
its increased productive encounters with the ppERK2 active site due to docking of the proximal F-site
at the kinase FRS.

The mitogen activated protein kinase (MAPK) ERK2, a serine/threonine kinase, is activated downstream
of the Ras-Raf-MEK cascade in response to a variety of extracellular cues including growth factors,
cytokines, hormones, neurotransmitters and osmotic stress1,2. ERK2 contains a canonical two-lobed catalytic domain characteristic of eukaryotic kinases. In lieu of external regulatory domains, it contains a
30-residue insertion (MAP kinase insert) between helices α G and α H in the catalytic domain as well as
an extended C-terminus3. Activation occurs upon dual-phosphorylation on an activation-loop TxY (x is
any amino acid) motif. Active ERK2 (ppERK2) is capable of phosphorylating a large array of substrates
located in the cytosol, in various cellular organelles and in the nucleus where ERK2 controls critical cellular processes including transcriptional activation4–6, chromatin remodeling7 and nuclear translocation8.
ERK2 mediated phosphorylation occurs on a consensus Px(S/T)P sequence, though only the (S/T)
P motif appears to be strictly necessary9,10. In spite of its functional necessity, this motif alone is not
sufficient to impart sufficient affinity or selectivity towards substrates10. In fact, ERK2 and other MAP
kinases utilize two modular docking sites11 located outside the active site of the enzyme to selectively
direct themselves to specific cellular targets. The first, termed the D-recruitment site (DRS)12,13, contains
two contiguous sub-sites: the Φ hyd sub-site located behind the ATP binding site provides mostly hydrophobic contacts; the Φ chg sub-site14, confined within a single loop, provides electrostatic stabilization.
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The DRS selects substrates that contain a so-called D-site (also called the D-domain or the DEJL motif)
sequence, R/KxxR/Kx1–6LxL15, which is located downstream of the phosphorylation motif. A host of
structural techniques including crystallography and NMR16 have revealed the interactions between
D-site sequences and the DRS. A second docking site, the F-recruitment site (FRS), is situated on a
surface opposite the DRS below the activation-loop. The FRS is fully formed only upon ERK2 activation17 and targets substrates carrying an F-site (also known as a DEF motif) consensus sequence (FxFP),
with phosphorylation sites located at variable distances from its N-terminus18,19. F-sites are found in
a variety of ERK2 substrates, most notably the transcription factors of the Ets-family, including Elk1, Lin-118 and Sap-120. In Elk-1, which contains both a D-site and an F-site, F-site/FRS interactions
have been demonstrated to drive phosphorylation to specific sites19,21 that are crucial for DNA binding
and transcriptional activation22. While hydrogen exchange mass spectroscopy (HXMS) combined with
site-directed mutagenesis has helped identify key ERK2 residues that form the FRS17, very little specific
insight is available on the structural and dynamic characteristics of F-site sequences, their interactions
with the FRS, and FRS-driven substrate phosphorylation. Using solution NMR techniques we investigated the interactions of ppERK2 with a 13-residue peptide derived from Elk-1 (Elk387-399) that encompasses a phosphorylation site (S389) and an F-site (F395-Q396-F397-P398). These studies represent the
first detailed analysis of the structural and dynamical characteristics of FRS/F-site docking and its role
in F-site driven phosphorylation. Our results suggest that while the two phenylalanine residues (of the
FxFP sequence) make significant stabilizing contacts with ppERK2 and appear to be critical for docking
interactions, the terminal proline is less important. We also find that the phosphorylation motif and
the F-site are uncoupled structurally and dynamically and while the former is disordered, making few
contacts with ppERK2, it is nevertheless phosphorylated. This provides support for the mechanism of
proximity-mediated catalysis that proposes that docking interactions serve to increase the effective local
concentration of the substrate moiety, thereby enhancing its probability of productively encountering the
ppERK2 active site resulting in phosphorylation23.

Results

Elk387-399 reduces conformational dynamics in ppERK2. We previously reported the partial backbone assignment of inactive ERK214,24; ppERK2, in contrast, exhibits behavior (rapid transverse relaxation,
tendency to aggregate at high concentration etc.) not conducive to standard backbone-directed resonance
assignment strategies. We noticed, however, that the presence of a five- to ten-fold excess of Elk387-399
results in significantly reduced relaxation rates that remain constant for concentrations upto ~200 μ M, and
produce spectra with significantly improved dispersion. Employing previously described methodology24
we were able to assign 213 15N, 1H resonances (63% of 338 amides expected; ~260 resonances observed
at 800 MHz) of ppERK2 bound to Elk387-399. Further, upon utilizing these resonance assignments and 15N,
1
H TROSY-based titrations of ppERK2 with Elk387-399 (and in few instances, by comparison with inactive
ERK2 spectra), we could assign 182 resonances belonging to ligand-free ppERK2 (54% of 338 expected;
~213 observed). Several resonances corresponding to residues in the MAPK insert (helices α 1L14, α 2L14
and the distal α L16), on helix α G, on the activation-loop, the P+ 1 loop (located at the back end of the
activation loop and involved in the docking of the critical proline residue on the substrate1,2), and on the
loop hosting the HRD motif (a conserved motif involved in the coordination of the substrate hydroxyl
group and in shaping the configuration of the overall catalytic machinery)1,2 are severely broadened (to
below the noise threshold) in free ppERK2, but re-appear in the presence of Elk387-399, suggesting significant quenching of dynamics in the μ s-ms timescale (Supplementary Fig. S1). Chemical shift perturbations
(CSP) observed for the critical Y26117 (rat ERK2 numbering used throughout) and for resonances belonging to helix α G indicate that, as expected, the peptide engages the FRS (Supplementary Fig. S1). However
CSPs alone do not allow a complete mapping of the peptide-binding site, since a number of ppERK2
resonances for residues in this region are not visible, especially in the absence of Elk387-399.
The FRS and DRS on ppERK2 are not allosterically coupled. An unexpected finding of our

NMR-based titration experiments was the observation that Elk387-399 also appears to engage the DRS at
high concentration. All the key components of the Φ hyd and Φ chg DRS sub-sites are extensively perturbed
(Supplementary Fig. S1), including Loop 4 (N80, G83), helix α D (L113), Loop 8 (T116-S120), helix
α E (D122-Y126), Loop 11 (L155-N156, T158-C159), Loop 16 (Y314-D316, D319) and helix α I (E303,
Q304). As further evidence that Elk387-399 does indeed engage the DRS, we noted a small but significant
increase in the KM (10.1 ±  0.8 μ M to 22.7 ±  2.8 μ M) for the phosphorylation of a high-efficiency D-site
containing substrate (ERK-sensor-D1, see Methods) in the presence of Elk387-399 (100 μ M) without any
concurrent changes in the Vmax (21.4 ±  0.5 and 23.4 ±  1.1 nM phosphate/second, Supplementary Fig. S2).
In order to confirm that the perturbations at the DRS reflect direct binding rather than some degree of
allosteric coupling between the FRS and the DRS, we tested the ability of Elk387-399 to bind inactive ERK2.
It is to be noted that the FRS is only formed fully in ERK2 upon activation17. A five to one excess of Elk387399 does not result in any significant perturbations at the FRS or in the activation-loop of inactive ERK2,
but perturbations, similar to those seen in the case of ppERK2, are seen at the DRS and the constituent
Φ hyd and Φ chg sub-sites (Supplementary Fig. S1). As a further control, we titrated ppERK2 with a DRS
specific ligand (KIM15-31, KD =  1.3 μ M); as previously reported for inactive ERK225, the only significant
CSPs are seen at the DRS and no significant long-range perturbations including at the FRS, are noted
Scientific Reports | 5:11127 | DOI: 10.1038/srep11127
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Figure 1. Spectral perturbations induced by Elk387-399 (kinase-to-peptide ratio 1:2.8) on ppERK2 in the
presence of a 20-fold excess of KIM15-31 with the KIM15-31-saturated state taken as reference. Perturbations
plotted against residue number are shown on the left panel. The right panel displays the perturbations
mapped onto the structure of ppERK2. Δ δ values that are 1.0σ , 1.5σ , 2.0σ , 3.0σ above the mean are
colored blue, green, purple and red respectively. The position of the critical Y261 on the FRS is indicated.
The FRS (brown), the activation-loop (blue) and the Φ chg (lime-green) and Φ hyd (pink) components of the
DRS are circled. The HRD and the P+ 1 motifs are indicated by blue and magenta arrows, respectively.
Residues that appear or disappear in the presence of Elk387-399 are colored orange and cyan, respectively for
both the left and right panels. Also shown is the sequence of Elk387-399 with the phosphorylation (SP) motif
(the phosphorylatable S389’ shown with a blue outline) and the F-site (FxFP) sequence shown in larger font
and colored red and green respectively.

(Supplementary Fig. S1). Finally, we repeated the titration of ppERK2 with Elk387-399 in the presence of a
saturating amount KIM15-31. In this case, the spectral perturbations seen at the FRS are reproduced while
the residues at the DRS do not show any further perturbations in the presence of increasing amounts
of Elk387-399 (Fig. 1). Thus as suggested by our previous kinetic studies on modular ERK2 substrates, the
DRS and FRS do not exhibit any direct allosteric coupling26.
Scientific Reports | 5:11127 | DOI: 10.1038/srep11127
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The interaction between Elk387-399 and ppERK2 may therefore be formally described as involving
binding to two independent sites (the FRS and the DRS) of unequal affinity. Due to the large difference
between the KD,FRS and the KD,DRS (see below), we were able to obtain an excellent estimate of the KD,FRS
using isothermal titration calorimetry (ITC) that employed lower concentrations of ppERK2 and Elk387399 than used for the NMR experiments (Supplementary Fig. S3a). Fitting the ITC data to a single-site
model (see justification below) produces a KD,FRS of 8.0 ±  0.9 μ M. This ITC-determined value was fixed
and used to globally fit the CSPs for specific DRS residues to a two-site exchange model (Supplementary
Fig. S3b) to obtain a KD,DRS of 242.0 ±  15.5 μ M (note for the ITC data, the occupancy of the DRS is ~6%
at an equimolar ppERK2:Elk387-399 ratio at the concentrations employed).

Spectral perturbations induced by ppERK2 on Elk387-399 suggest localized interactions between
the FRS and the F-site. In order to further investigate the mechanism of FRS-directed substrate rec-

ognition and phosphorylation we produced Elk387-399 labeled with NMR-active isotopes (uniformly-15N,
C or uniformly-15N, 2H, 13C-labeled) and probed its interactions with unlabeled (or 2H-labeled) ppERK2.
The 1H, 15N HSQC (or TROSY) based titrations allowed classification of the amide resonances into two
main groups suggesting a difference in their overall structural and dynamic characteristics upon docking
onto ppErk2 (Fig. 2a). Amides belonging to residues encompassing the L393’-F397’ fragment (Elk387-399
residues are italicized and primed) that includes the F-site (FxFP) disappear at early stages of the titration
when 14-28% of Elk387-399 is bound to ppERK2, and do not reappear even when ~97% of uniformly 2H,
15
N-labeled Elk387-399 is bound to 2H-labeled ppERK2. The fact that protonated and deuterated samples
show similar behavior suggests that the signal disappearance observed in the L393’-F397’ segment is
the result of chemical exchange on the intermediate timescale rather than efficient relaxation due to
the slow molecular tumbling of the complex. These resonances were not recovered even at saturating
concentrations of ppERK2, suggesting that the exchange phenomenon likely involves structural fluctuations occurring after complex formation. The remaining amides, including the phosphorylation target
S389’, display no significant line broadening and are detectable at every stage of the titration (Fig. 2a),
suggesting that they retain a high degree of flexibility in the complex. It should be noted that, given the
tendency of Elk387-399 to also bind at the DRS, albeit at high-concentrations, the CSPs described above
for uniformly-15N, 13C labeled Elk387-399 were obtained in the presence of ppERK2 containing saturating
amounts of KIM15-31 to block the DRS, and reflect interactions exclusively with the FRS.
A higher level of detail on the role of specific sidechains of Elk387-399 in its interactions with ppERK2
was obtained from 13C, 1H HSQC-based titration acquired up to an equimolar Elk387-399 to ppERK2
ratio (78% bound). In order to compare the magnitudes of the perturbations for different sidechain
positions (Fig. 2b), we extended the concept of residue-specific weighting factor, previously introduced
by others27, to include sidechain atoms. Briefly, we postulate that the distribution of chemical shifts
deposited in the BMRB (http://www.bmrb.wisc.edu) for a given atom reflects the variety of chemical
environments experienced by it in the entire protein fold space. For a given atom, we expressed the perturbation (Δ sc, Equation 2) experienced upon binding as the percent chemical shift change with respect
to the standard deviation of BMRB-deposited chemical shifts for that atom. As a first approximation,
when two chemically distinct moieties undergo comparable conformational changes their corresponding
Δ sc values are predicted to be similar. A number of sidechain resonances for the L393’-F397’ fragment
broaden beyond the threshold of detection at the same stages of the titration as seen for the backbone
amide resonances (Fig. 2b). This includes all α -positions (except L393’ α ), and the β -positions of L393’,
F395’, Q396’ and F397’. However, the peripheral positions for the long-chain amino acids (L393’ γ , δ 1,2;
S394’ β ; Q396’ δ , ε ) and to a lesser extent, the aromatics, though significantly broadened, maintain sufficient mobility on the ps-ns timescale, to be detectable at an equimolar concentration of Elk387-399 and
ppERK2 (Fig. 2b). The largest Δ end,sc values (Δ sc at the titration end-point) also predominantly cluster
on the L393’-F397’ fragment where the average perturbation per residue is consistently above 20%. In
particular, aromatic resonances corresponding to F395’ and F397’ and the β -methyl resonances of L393’
displayed Δ end,sc values of approximately 30%. These represent large perturbations in absolute terms
and strongly suggest direct contact between these Elk387-399 sidechains and ppERK2. In comparison, at
the far C-terminus of Elk387-399, not only are resonances corresponding to all positions of P398’ (the
last residue of the FxFP motif) visible at the end of the titration, they show significantly smaller Δ end,sc
values than the still observable resonances of the neighboring L393’-F397’ fragment. The terminal S399’
showed vanishingly small Δ end,sc values. At the N-terminus around the SP phosphorylation motif, the
largest average perturbation is seen for P390’; the phosphorylation target, S389’ shows similar changes
at the α position, but the β position displays a very small but detectable Δ end,sc. The first two residues
at the N-terminus of Elk387-399 do not display any significant Δ end,sc. Importantly, the addition of MgCl2
followed by a saturating amount of AMPPCP (which contains a non-transferable γ phosphate) does
not significantly affect S389’ or any other resonances. Yet, incubation of Elk387-399 with ATP/Mg2+ and
ppERK2 converts S389’ entirely into phospho-serine (enzymatic assays suggest a kcat= 0.56 ±  0.1 sec−1;
KM= 13.4 ±  1.1 μ M; Supplementary Fig. S4a), as indicated by the characteristic large downfield chemical
shift changes observed for S389’ (for the amide resonance and for that corresponding to the β position,
Supplementary Figs. S4b,c)28. This confirms that Elk387-399 is a viable substrate for ppERK2 under the
conditions employed for our NMR experiments.
13
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Figure 2. Spectral perturbations induced by ppERK2 on Elk387-399. (a) Chemical shift perturbations (Δ i,sc)
at various stages of the titration shown for amides exhibiting both resonances belonging to trans-containing
(dark-blue) and cis-containing (light-blue) conformers. (b) Chemical shift perturbations (Δ end,sc) at the
titration end-point for nitrogen-containing (blue) or carbon-containing positions (green). The colors of the
bars become progressively lighter with the position along the length of the sidechain. Light grey and dark
grey bars indicate backbone amide and aliphatic positions, respectively, that disappear during the course of
the titration. Data were acquired at 700 MHz.

We were also able to measure the 15N spin-spin relaxation times (T2) at 600 MHz (Fig. 3a) for the
still-visible residues of Elk387-399 (61% bound): S389’ (212 ms), A391’ (157 ms), K392’ (164 ms), L393’
(181 ms) S399’ (127 ms) and cis-containing minor states (Fig. 3b) for S389’ (242 ms), A391’ (228 ms),
K392’ (154 ms), F395’ (80 ms) and Q396’ (73 ms). Assuming a fast-exchange regime such that the measured relaxation times are population-weighted averages of those in the free and bound states, then the
extrapolated fully bound T2 values for the S389’-K392’ segment were found to lie in the 107-149 ms range
(Fig. 3c). These values lie between those for the amides of the rigid core of Elk387-399-bound ppERK2
(Fig. 3d; ~30 ms, indicative of a monomeric ppERK2 in line with previous results29) and its flexible N
Scientific Reports | 5:11127 | DOI: 10.1038/srep11127
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Figure 3. Backbone 15N transverse relaxation times (T2) for the (a) major all-trans and (b) minor ciscontaining components of Elk387-399. Data is shown only for those resonances that are observable in the
state that is 61% bound to ppERK2 (assuming a KD =  8 μ M). T2s for the 100% bound state are extrapolated
from those of the free and 61% bound states assuming a fast exchange on the timescale defined by the
relaxation rates. Extrapolated fully bound T2 values are only shown for those residues (S389’, A391’, K392’
and S399’) that display minimal line broadening during titration course and are in the fast exchange regime.
Note that residues P390’ and P398’ are prolines and resonances close to the F-site disappear early in the
titration course. The cis-containing conformers of F395’ and Q396’ show T2 values in 61%-bound state that
are significantly shorter than those of the N-terminus and approach those of the core residues of ppERK2
(shown in panel d, see below) containing saturating amounts of Elk387-399. This suggests that the F-site
sequence in these minor states also engages the ppERK2 FRS. An expansion of the extrapolated T2s of the
all-trans conformers of Elk387-399 when fully-bound to ppERK2 is shown in (c) on the same scale as those
of ppERK2 in the presence of saturating amounts of Elk387-399 (d) to allow direct comparison. It is evident
that the T2 values for the N-terminus of Elk387-399 are higher than those for the ppERK2 core but shorter
than those in the extreme N- and C-termini. This suggests that while the N-terminus of Elk387-399 is partially
constrained by its F-site that is firmly docked onto ppERK2, it is still flexible.

Scientific Reports | 5:11127 | DOI: 10.1038/srep11127
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Figure 4. 15N relaxation dispersion curves for selected Elk387-399 residues that are observable when 61%
bound to ppERK2 in the presence of Mg2+/AMPPCP. The open circles represent experimental R2,eff values
and the solid lines represent fits to the fast exchange equation (Equation 4) using a global kex value. Data for
S389’, A391’, K392’, the cis-containing minor state of Q396’ (shown in green) and the C-terminal S399’ were
used in the global fit that yielded kex =  1178 ±  87 s–1. Note the significantly higher R2,eff (∞) value for Q396’
(cis) compared to those of the N-terminal residues.

(350 ms) and C-terminal tails (150 ms) (Fig. 3d). Taken together, the spectral perturbations and relaxation data support the scenario in which the bulk of the interactions between Elk387-399 and the ppERK2
involve the side chains of L393’, F395’, F397’ and, to a lesser extent, K392’, Q396’ and P398’. This segment
docks onto the surface of ppERK2 and the N-terminus including the phosphorylatable S389’ remains
disordered. Additionally, the lack of significant response to the presence of Mg2+/AMPPCP suggests that
the small CSPs observed for P390’ and, to a lesser extent, the α position of S389’ (note that the β position
shows no significant CSP, Fig. 2b) do not originate from the rigid positioning of the phosphorylation
motif in the active site cleft but rather by non-specific collisions with the kinase surface (see below).

Proline cis-trans isomerization has distinct effects at the F-site and the phosphorylation
motif in Elk387-399. Minor states resulting from the cis conformations (Supplementary Fig. S4b) around

the S389’-P390’ and F397’-P398’ peptide bonds (identified based on the differences in their 13Cβ and
13
Cγ chemical shifts30; Δ Cβ γ cis and Δ Cβ γ trans for P390’ are 9.3 ppm and 4.7 ppm, respectively; the corresponding values for P398’ are 9.5 ppm and 4.7 ppm, respectively) are detectable in free Elk387-399. These
resonances are visible not only for S389’ and F397’, but also for every other position except for S394’
and S399’. The relative intensities of these resonances suggest that they belong to conformers containing
a single cis-proline.
As in case of the amide resonances corresponding to the all-trans form discussed above, resonances
corresponding to the cis-containing forms at the C-terminal end of Elk387-399 disappear at the early stages
of the titration, while those at the N-terminus are only modestly perturbed and can be detected even at
high ERK2 concentrations (Fig. 2a). The S389’ and A391’ amide resonances in the cis-containing forms
survive throughout the titration course but display significantly smaller CSPs compared to their all-trans
counterparts. In contrast, the L393’, F395’, Q396’ and F397’ resonances for cis-containing forms show
small CSPs like their all-trans counterparts (as discussed above) and also vanish at the same stage of the
titration course, suggesting very similar behavior (Fig. 2a). Additionally, the 61%-bound T2 values for
F395’ (80 ms) and Q396’ (73 ms) resonances in the cis-containing conformers (due to a cis orientation of
the F397-’P398’ peptide bond) (Fig. 3b), approach those of the residues belonging to the structured core
of ppERK2 (Fig. 3d) and are significantly shorter than those of the N-terminus discussed above. These
observations indicate that cis-trans isomerization around the F397’-P398’ peptide bond does not have
a significant effect on the F-site/FRS interactions and suggest a less critical role for the proline residue
of the FxFP motif in line with previous suggestions18,31. In contrast, the relatively large CSPs for S389’
and A391’ amide resonances in the all-trans and the significantly smaller ones in the cis forms (Fig. 2a)
suggest that isomerization around S389’-P390’ peptide bond further compromises the already weak
interaction of the N-terminal phosphorylation site with the kinase. This observation is consistent with
the previously demonstrated inability of ppERK2 to phosphorylate a substrate containing a cis-proline
immediately following the phospho-acceptor32.

Elk387-399 binds ppErk2 through a diffusion-controlled process. We performed

N relaxation
dispersion experiments on Elk387-399 (61%-bound; the DRS was blocked using KIM15-31 and an excess
of AMPPCP/Mg2+ was added to fully populate the ATP binding site such that the docked complex
15

33
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represents the assembled pre-catalytic state). The effective relaxation rates for the still observable residues S389’, A391’, K392’, L393’, S399’ belonging to the all-trans conformer, and the Q396’ resonance of
a cis-containing conformer (that has a significantly higher R2,eff value indicating that it is indeed docked
on to ppERK2) display a clear variation with radio-frequency field strength (Fig. 4). These dispersion
curves can be fitted using a single (probability for a global fit >99.98% based on Akaike Information
Criterion) global exchange rate (kex =  1178 ±  87 sec−1). The proline cis-trans isomerization is too slow
to contribute to the kex. The fact that both the N-terminal residues and the C-terminal S399’ displayed
the same kex suggests that the observed exchange is also not due to the sampling of the active site by
the N-terminus bearing the phosphorylation motif. This leads to the conclusion that this kex value characterizes the ppERK2 binding/unbinding process of Elk387-399. Based on the KD,FRS determined above,
one can estimate a kon =  5.6 ±  1.0 ×  107 M−1 sec−1, suggesting a largely diffusion controlled association,
and a koff =  451 ±  140 sec−1 corresponding to a lifetime of ~2 ms for the bound state. Based on the kcat
(0.56 ±  0.1 sec−1, see above) one can estimate that only 1 in about 800 docking events result in productive
catalysis.

F-site phenylalanines but not the proline make critical contacts with ppERK2 in the
Elk387-399•ppERK2 complex. The interaction between Elk387-399 and ppERK2 is relatively weak and

ab initio structure determination of the complex without substantial protein engineering (that is likely
to perturb the interaction) is not possible. Therefore we relied on exchange-transferred 1H-1H NOEs
(trNOE)34 to obtain structural insight into the conformation of Elk387-399 bound to ppERK2. While
15
N-edited (or 13C-edited) 1H-1H NOESY experiments on Elk387-399 in the absence of ppERK2 suggest a
less than ideal situation with the detection of a number of cross-peaks especially in the Hα -HN region, a
clear increase in the number of cross-peaks and a significant increase in the intensities of existing peaks
is seen upon addition of the ppERK2 (Supplementary Fig. S5 illustrates the appearance of transferred
NOE cross-peaks in a 13C-edited 2D 1H-1H-NOESY experiment when ppERK2 is added to a NMR sample containing the Elk387-399 peptide). Using this strategy, we were able to identify 95 unambiguous and
17 ambiguous NOEs for Elk387-399 bound to ppERK2 from 3D 15N and 13C edited NOESY experiments.
The conspicuous lack of medium range (particularly at the C-terminal region that engages ppERK2)
and sequential HN-HN NOEs indicates that Elk387-399 adopts an extended conformation when bound to
ppERK2.
In order to obtain a structural model for the Elk387-399•ppERK2 complex we relied on a
HADDOCK-based35,36 docking protocol utilizing the experimental restraints described below. We used
the crystal structure of ppERK2 (PDB ID: 2ERK)37 and 5 representative structures selected from the
lowest energy ensemble of Elk387-399 (40 structures) obtained from a calculation (see Methods for details)
utilizing the Aria38 suite and the intramolecular distance constraints described above38. As detailed earlier
(spectral perturbations and relaxation analyses) our data clearly indicates that the N-terminal P387’-A391’
segment of Elk387-399 does not participate in any stabilizing interactions with ppERK2, therefore only the
K392’-S399’ fragment (capped by an N-terminal acetyl group) was included in the HADDOCK calculations. The experimentally determined intramolecular NOEs identified in this portion of the peptide
(75 unambiguous and 16 ambiguous restraints) were included in the docking calculations. Typically,
intermolecular ambiguous distance constraints involving all atoms for an interacting residue are used in
HADDOCK-based docking calculations to drive the docking process. However, given the availability of
spectral perturbations (CSPs and line broadening) of both backbone (as is usual) and sidechain positions
for Elk387-399, we decided to use only those specific moieties that displayed significant perturbations (CSPs
or line-broadening or appearance/disappearance) when titrated with ppERK2 (e.g. L393’ δ methyls, the
aromatic rings of F395’ and F397’, the sidechains of Q396’ and K392’) to generate ambiguous intermolecular distance restraints. For ppERK2, interacting residues were defined based using both the spectral
perturbations obtained here and data from previous mutational analyses17,31. In particular, I196, M197,
L198 and L235 were included based on the findings of Sheridan et al31, while the involvement of the
activation loop was decided based on the NMR data presented above.
The HADDOCK models are clustered within an RMSD of 2.5 Å for atoms at the Elk387-399•ppERK2
interface. While the lack of precise intermolecular restraints and the low density of intra-Elk387-399 distance restraints prevented convergence to a single unambiguous low energy configuration, all the models
obtained share similar overall features. Elk387-399 forms an extended structure and the sidechains belonging to F395’ and F397’ are buried in two contiguous hydrophobic pockets (Fig. 5a). The first of these
pockets is formed by I196, M197 (P+ 1 loop) and the aromatic ring of pY185; the second is formed by
Y261, A258 (helix α L1), L232, L235 (helix α G) and L198 (P+ 1 loop). L393’ is more solvent exposed, but
its aliphatic side chain also interacts with Y231 (helix α G). Finally, the K392’ sidechain interacts with the
activation-loop and makes both electrostatic and hydrophobic contacts; in the models belonging to the
lowest energy HADDOCK cluster, these largely involve pY185, while the charged groups of E184 and
pT183 are involved in the higher energy clusters (Fig. 5b). The P398’ ring lies at the periphery of the
binding pocket, is more solvent exposed and makes a lesser number of contacts with the ppERK2 surface,
in line with the limited perturbations seen in the NMR titrations. Based on these data, F395’ and F397’
appear to be critical for interactions of Elk387-399 with ppERK2, while P398’ is relatively unimportant.
The latter observation contrasts the HXMS-based model proposed by Lee et al.17, but is in line with the
biochemical results of Sheridan et al.31.
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Figure 5. Structural features of the Elk387-399•ppERK2 complex. (a) The lowest energy structure of Elk387-399
docked onto the ppERK2 surface. The ppERK2 residues that form the two hydrophobic cavities (indicated
by the dashed circles) that accommodate F395’ and F397’ are labeled in green and blue lettering, respectively.
The ppERK2 surface has been colored using the Eisenberg generalized hydrophobicity scale59 (deeper
red indicating more hydrophobic). The pT183 and pY185 residues are colored light sea blue. (b) Ribbon
representation showing the best HADDOCK structure for the lowest energy cluster (Elk387-399 is colored dark
green and ppERK2 is colored pink, pY185 is shown in stick representation) compared to two structures
belonging to 2nd best HADDOCK cluster. For these, only the Elk387-399 ribbons are shown and colored pale
and light green; their respective closest ppERK2 charged sidechain (E184, light blue, and pT183, dark blue)
are shown as sticks. For each model, the side chains of K392’, F395’, and F397’ on the Elk387-399 structures are
also shown as sticks. K392’ interacts with the pT183-E184-pY185 segment (activation-lip) of the ppERK2
activation-loop in all cases. Potential hydrogen hydrogen-bonding interactions of the K392’ sidechain with
the ppERK2 activation lip are shown as dashed magenta lines: pY185 in the lowest energy structure; E184 or
pT183 in the two higher energy ones. F395’ and F397’ show similar spatial orientations in all three cases.

Discussion

Elk387-399 appears to engage ppERK2 by the insertion the F-site phenylanine aromatic rings (F395’, F397’)
into two hydrophobic pockets with minimal involvement of the F-site proline (P398’). Data from a study
by Sheridan et al.31 demonstrated the strict requirement for aromatic residues at the first and third positions of the F-site while replacement of the proline with phenylalanine, tryptophan or glutamine results
in no appreciable loss in phosphorylation efficiency in an F-site containing substrate. We also find that
while a trans conformation of the proline in the phosphorylation (S389’-P390’) motif is necessary, a cis
F397’-P398’ peptide bond does not appear to prevent binding to the FRS. The latter scenario could be
physiologically relevant, given that this segment in full-length Elk-1 is predicted to be disordered and cis
conformers could represent up to 20% of the structural ensemble. The lifetimes of these cis-containing
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states could range anywhere between several seconds to several minutes39, comparable to the cellular
lifetimes of ppERK2 upon transient activation40.
While there are no high-resolution structures of complexes that illustrate F-site/FRS interactions, a
crystal structure of ppERK2 bound to the anti-apoptotic protein PEA-15 that partially engages the FRS is
available41. This small adaptor protein does not contain canonical D-site or F-site sequences and attains
high-affinity in its interaction with ppERK2 by simultaneously engaging the Φ hyd sub-site of the DRS and
a part of the FRS. Interestingly, in the PEA-15•ppERK2 complex the hydrophobic pockets occupied by
F395’ and F397’ (in the complex with Elk387-399) are occupied by the P73 ring and by the alkyl portion of
the R71 side-chain of PEA-15 (Supplementary Fig. S6). However a feature common to the Elk387-399 and
PEA-15 complexes is their contact with the ppERK2 activation loop; the possibility of such interactions
was first raised in HXMS studies of Lee et al.17 In Elk387-399, this interaction is mediated by K392’ and in
PEA-15 by R71, despite being in different spatial orientations.
Our results also demonstrate that, upon interaction with Elk387-399, the activation-loop, the P+ 1 loop
as well as the contiguous loop hosting the HRD motif become more ordered. Resonances for these
regions of ppERK2, together with part of the MAPK insert also involved in binding Elk387-399, are not
detectable in 15N, 1H TROSY spectra of ppERK2 in the absence of Elk387-399, suggesting the existence of
significant dynamics on the μ s-ms timescale in the unbound state. Methyl relaxation studies have previously identified these segments to be dynamic on the ms timescale42; these dynamics have been shown
to be enhanced in the active form of the kinase, and are believed to involve an oscillation of the system
between catalytically-competent active and inactive-like conformational states. Our results suggest that
Elk387-399 binding at the FRS stabilizes the activation loop and other portions of the catalytic machinery
in what is likely an active-like conformation. Similar stabilization is not seen in the presence of D-site
ligands such as KIM15-31.
A curious observation in our studies was the engagement of the DRS by Elk387-399 at high concentrations (KD,DRS =  241 μ M). Specifically, the spectral perturbations seen at the Φ hyd sub-site for both active
and inactive ERK2 are strikingly similar to those induced by KIM15-31. While the biological relevance
of this finding is debatable, care should be taken while analyzing in vitro data from studies that employ
F-site and D-site containing ligands simultaneously20,26. Given the significantly weaker affinity compared
to a canonical D-site/DRS interaction, it is unlikely that the binding of Elk387-399 at the DRS on its own
could mediate the phosphorylation of specific Elk-1 sites in vivo. It is conceivable, however, that these
types of weak interactions could contribute additively towards the formation of a tighter complex by
engaging multiple docking sites through non-canonical interactions. Interestingly, DRS mutations result
in a 2-3-fold increase in the apparent KD of the interaction of ppERK2 with the F-site containing c-Fos21.
In contrast, an Elk-1 mutant where the D-site is replaced by a second F-site exhibits only a 2.5-fold
increase of the KM, while a 9-fold increase is observed if only the native F-site is retained19. PEA-1514,41
and the transcription factor Ets-143,44 efficiently bind ERK2 despite the fact that neither protein possesses
a canonical D-site or a canonical F-site. These cases provide examples of engaging multiple docking sites
through non-canonical interactions that, while weak individually, lead to significantly enhanced affinity
in synergistic combination.
Another major finding of this study is the independence of the F-site and the phosphorylation motifs.
The spectral perturbations, and 15N relaxation data indicate that the P387’-R388’-S389’-P390’ fragment is
largely unrestrained and undergoes fast motions on the ps-ns timescale, populating the ppERK2 active
site only transiently, while the F-site is relatively rigidly docked onto the ppERK2 FRS. This scenario
suggests proximity-mediated phosphorylation23 involving the initial formation of a high-affinity complex
with the involvement of the docking motif, followed by a second process that brings the phospho-acceptor
into the catalytic site. We are unable to directly measure the insertion rate of the substrate serine (S389’)
into the catalytic cleft. However, a lack of evidence for unique exchange processes involving S389’ in the
relaxation dispersion experiments beyond the global dynamics caused by the binding/unbinding events,
suggests that this phenomenon is significantly faster than docking (and outside the dynamic regime of
the CPMG-based dispersion experiments). An alternative scenario in which binding and sampling of the
catalytic site take place on the same timescale appears highly unlikely since this would produce significant transient chemical shift changes (Δ ω in Equation 4, see Methods) for S389’ in relaxation dispersion
measurements, not seen here (data not shown).
It is now established that a proline residue following a serine/threonine phospho-acceptor is essential
for efficient phosphorylation by MAP kinases31. A QM/MM study45 on ppERK2 suggests that the proline
of the substrate (S/T)P motif needs to be accommodated within a hydrophobic cleft formed by L168 and
the aromatic ring of pY185 to enable the optimal positioning of the phospho-acceptor within the kinase
catalytic site. However, trapping of the proline within this cavity leading to the formation of a catalytically competent Michaelis-Menten complex is a relatively rare occurrence (Keq  1)44 and the largely
non-productive clashes of the proline ring with this hydrophobic cleft dominate the sampling events.
We suspect that the CSPs observed for P390’, that are independent of the presence of Mg2+/AMPPCP,
result from these clashes.
Our results conclusively demonstrate the importance of the phenylalanine residues within F-site
sequence for interactions with ppERK2 but not the F-site proline. This is demonstrated by smaller spectral perturbations, minimal stabilizing contacts with the kinase and the apparent ability of the kinase to
dock conformers that contain cis-proline at the terminal F-site position. FRS/F-site interactions stabilize
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Figure 6. A model for FRS-driven phosphorylation of Elk387-399 by ppERK2. The initial diffusioncontrolled docking interaction reduces the dynamics (represented by the blurred images; the blurs represent
μ s-ms timescale dynamics on ppERK2 and ps-ns timescale dynamics on Elk387-399) at the ppERK2 FRS
(brown) and in the activation-loop (blue; pT183 and pY185 are represented by the dark blue spheres).
The F-site phenylalanine residues (F395’ and F397’ green spheres) dock into two hydrophobic pockets at
the FRS. The N-terminal SP motif (S389’ represented by the yellow sphere; P390’ represented by the red
sphere) remains disordered and has largely unproductive encounters with the ppERK2 active site. The
probability of these encounters (both productive as well as unproductive) is increased by the FRS/F-site
docking and resultant increase in the local concentration of the phospho-acceptor near the kinase active
site. A productive encounter leads to the formation of a stable Michaelis complex ultimately resulting in the
phosphorylation of S389’ (dark blue sphere).

the activation and P+ 1 loops and a part of a MAPK insert that sample multiple conformations when the
FRS is unoccupied. Our data also suggest a lack of coupling between the F-site and the phosphorylation
motif with the latter remaining largely disordered even when the former is docked onto the kinase FRS.
In spite of this flexibility, phosphorylation can occur due to the increased local concentration of the
phosphorylation moiety and the resultant increase in the probability of a productive encounter with the
kinase catalytic site (shown schematically in Fig. 6).

Methods

Expression and purification of Elk387-399. Synthetic DNA corresponding to a 13-residue peptide
(387PRSPAKLSFQFPS399, Elk387-399) encompassing the F-site (in bold) and an N-terminal phosphorylation site (S389, bold italics) of Elk-1 was sub-cloned into the pTMHa vector carrying a TrpLE leader
sequence46 between the HindIII and BamHI restriction sites and transformed into E. coli BL21 (DE3)
cells (New England Biolabs). Cells were grown in LB containing 50 mg/L of Kanamycin at 37 °C up to
an OD600 of 0.8, pelleted down by centrifugation and washed with ice-cold M9 solution. The pellet was
re-suspended in M9 medium, supplemented with 15NH4Cl (1 g/L) and uniformly-13C-labeled glucose
(3 g/L) (Cambridge Isotope Laboratories) as the only sources of nitrogen and carbon, respectively. After the
OD600 reached 0.8, protein overexpression was induced with 1 mM isopropryl-β -thiogalactopyranoside
(IPTG); cells were grown for 5 hours at 37 °C under agitation. Following this, cells were harvested by
centrifugation at 4000 rpm at 4 °C and lysed by sonication in a buffer containing 50 mM Tris pH 8,
1 mM EDTA, 100 mM PMSF, and 10 mg/mL of lysozyme. The resulting suspension was centrifuged at
16000 rpm for 20 minutes at 4 °C to isolate the inclusion bodies containing the TrpLE-Elk387-399 fusion.
The resulting pellet was washed extensively with a mild detergent solution containing 50 mM Tris, 1 mM
EDTA and two detergents, 1% IGEPAL CA30 and 1% deoxycholic acid (Sigma) followed by sonication
in water and subsequent centrifugation at 18,000 rpm for 20 minutes at 4 °C. The pellet containing the
inclusion bodies was then dissolved in 100% trifluoroacetic acid (TFA) by sonication. The TrpLE segment was cleaved from the fusion protein with cyanogen bromide using established strategies47. The
cleavage reaction was performed in the dark inside Teflon sealed HPLC vials in the presence of 80%
TFA. Pure 13C, 15N-labeled Elk387-399 peptide was obtained through reverse phase chromatography using
a C18 HPLC column (VYDAC), and the identity of the peptide was confirmed by LC-MS. Uniformly
15
N, 13C, 2H-labeled Elk387-399 was prepared in similar fashion by replacing 13C-labeled glucose with 13C,
2
H-labeled glucose and switching to a D2O-based medium after adapting cells for growth in D2O as
described previously48.
Expression and purification of ppERK2. The expression and purification of ERK2 for NMR studies

has been described in detail elsewhere14. The purified inactive protein was dialyzed into activation buffer
containing 20 mM HEPES pH 7.5, 500 μ M EGTA, 20 mM MgCl2, 2 mM DTT, and concentrated to 7 μ M.
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The purified inactive ERK2 was activated using 0.35 μ M of MKK1G7B (a constitutively active mutant of
MEK1)49, and a total of 12 mM ATP (added at different intervals in 4 mM aliquots), and by incubating
the reaction mixture at 27 °C for 8 hours. The activated protein (ppERK2, dually phosphorylated on
T183 and Y185) was dialyzed into a buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, 2.5 mM CaCl2,
0.1% β -mercaptoethanol, and purified using a MonoQ column (GE Healthcare Biosciences). The purified
ppERK2 was then injected on a Superdex75 HiLoad 16/60 column equilibrated with the desired NMR
buffer; activation was confirmed by mass-spectroscopy.

Isothermal titration calorimetry measurements. All isothermal titration calorimetry (ITC) meas-

urements were performed on an iTC200 microcalorimeter (GE Healthcare Biosciences) at 25 °C. Both
Elk387-399 and ppERK2 were extensively dialyzed against a buffer containing 50 mM sodium phosphate
pH 6.4, 150 mM NaCl, 0.5 mM EDTA, and 0.1 mM EGTA. All solutions were filtered using membrane
filters of pore size 0.22 μ M (Millipore) and degassed for about 30 minutes under vacuum. The sample cell
(volume 200 μ L) was filled either with a 50 μ M solution of ppERK2 or buffer alone. A syringe of volume
40 μ L was filled with 0.75 mM of unlabeled Elk387-399 (commercially synthesized and HPLC purified;
Anaspec). Titration steps consisted of a preliminary 0.2 μ L injection followed by 14 injections of 0.25 μ L
each. The data were fitted to a simple one-site binding model, using the ITC module embedded within
the Origin 7.0 suite. The data described is representative of experiments collected in duplicate.

NMR spectroscopy and resonance assignments. All NMR experiments were performed at 25 °C
on Bruker Avance (500, 600, 700 or 800 MHz) or Varian Inova (600 MHz) spectrometers, all equipped
with cryogenic probes with z-axis pulsed-field gradient capability. All spectra were processed using
NMRPipe50 and analyzed using either Analysis (CCPN)51 or NMRView 52.
Typical NMR samples for assignment of ppERK2 bound to Elk387-399 consisted of 200–300 μ M uniformly 2H, 15N, 13C-labeled ppERK2 with 2–3 mM unlabeled Elk387-399 in a buffer containing 20 mM MES
pH 6.4, 150 mM NaCl, 2 mM DTT, 200 μ M EDTA. The assignment strategies for ppERK2 alone and that
bound to Elk387-399 will be described in detail elsewhere (Piserchio et al., in preparation).
Samples used to obtain resonance assignments for Elk387-399 contained uniformly 15N, 13C-labeled
Elk387-399 (around 300 μ M) in a buffer containing 50 mM phosphate pH 6.5, 150 mM NaCl and 0.5 mM
EDTA. Resonance assignments were obtained using a standard backbone-directed triple-resonance strategy53 using: 3D-HNCACB and 3D-CBCA(CO)NH (512, 20 and 32 complex points and sweep-widths of
10, 20 and 75 ppm in the 1H, 15N and 13C dimensions respectively), 3D-(H)C(CO)NH-TOCSY (512, 20
and 40 complex points and sweep-widths of 10, 20 and 53 ppm in the 1H, 15N and 13C dimensions respectively), and 3D-HCCH-TOCSY (512, 40 and 40 complex points and sweep-widths of 10 and 53 ppm
in the 1H and 13C dimensions respectively; mixing time =  18 ms). The aromatic resonances (F395’ and
F397’) were assigned using the pulse sequences of Yamazaki54 using 512 and 28 complex points with
sweep-widths of 12 and 24 ppm in the 1H and 13C dimensions, respectively.
Titration of labeled ppERK2 with Elk387-399 and KIM15-31.

Spectral perturbations on ppERK2 were
assessed from 15N, 1H TROSY experiments at 600 MHz and 25.0 °C using 1024 and 128 complex points
and sweep-widths of 15 and 33 ppm in the 1H and 15N dimensions, respectively. A 100 μ M sample of
ppERK2 in a buffer containing 50 mM phosphate pH 6.8, 150 mM NaCl, 200 μ M EDTA, 8 mM DTT,
was titrated with (1) the following amounts of Elk387-399: 25.0, 49.4, 73.1, 96.2, 124.3, 177.85, 458.0, 729.9,
993.93 μ M; or (2) with the following amounts of Elk387-399: 25.0, 49.8, 97.8, 157.7, 276.8  μ M in the presence of 2.0 mM of KIM15-31. A 130 μ M sample of ppERK2 in a buffer containing 50 mM HEPES pH
6.8, 150 mM NaCl, 200 μ M EDTA and 2 mM DTT was titrated with the following amounts of KIM15-31:
49.2, 99,8, 149.0, 296.2, 450.6, 992.0 μ M. Finally, two spectra were also collected for a 150 μ M sample of
inactive ERK2 alone and in the presence of 507 μ M of Elk387-399 in phosphate buffer (described above).

Titration of labeled Elk387-399 with ppERK2. A reverse titration of uniformly 15N,13C-labeled Elk387-

with ppERK2 was performed in the following way: initially, reference spectra (see below) were collected for a sample with an equimolar amount (130 μ M) of both species in a buffer containing 20 mM
MES pH 6.0, 150 mM NaCl, 500 μ M EDTA, 10 mM DTT, following which 140 μ M of KIM15-31 was
added; next the sample was progressively diluted with NMR buffer containing 130 μ M uniformly 15N,
13
C-labeled Elk387-399 and 140 μ M of KIM15-31 leading to the following ppERK2 concentrations: 130, 110,
90, 60, 40, 20, 10, 5 μ M. For each dilution point aliphatic 13C, 1H HSQC (15 and 50.4 ppm for the 1H
and 13C dimensions, respectively), aromatic 13C, 1H HSQC (15 and 7 ppm for the 1H and 13C dimensions,
respectively) and 15N, 1H HSQC (15 and 9 ppm for the 1H and 15N dimensions, respectively) experiments
were collected at 25 °C at 700 MHz. The same experiments were repeated at 15° C using the following
final concentrations of ppERK2: 130, 110, 60, 20, 5, 0 μ M. Similar 13C, 1H and 15N, 1H HSQC experiments
were also collected on a 180 μ M uniformly 15N, 13C-labeled Elk387-399 sample containing 130 μ M ppERK2
in the presence of 140 μ M KIM15-31 in the MES buffer (described above) supplemented with 5 mM MgCl2
and 400 μ M AMPPCP at 25.0 °C and 600 MHz.
399
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Effects of Elk387-399 phosphorylation. The spectral perturbations resulting from phosphorylation of
the Elk387-399 peptide was evaluated by adding 6.35 mM ATP to a solution containing 50 mM phosphate
pH 6.5, 150 mM NaCl, 5 mM DTT, 0.5 mM EDTA, 33 μ M ppERK2 and 400 μ M Elk387-399, in the presence
of 8.3 mM MgCl2. Chemical shift changes due to phosphorylation of Elk387-399 peptide were monitored
using 15N, 1H HSQC experiments (4 transients; 1024 and 128 complex points for sweep-widths of 10 and
12 ppm in the 1H and 15N dimensions, respectively) and 13C, 1H HSQC experiments (1024 and 256 complex points for sweep-widths of 10 and 60 ppm in the 1H dimension and 13C dimensions, respectively).
Analysis of spectral perturbations. Chemical shift perturbations (CSP, Δ δ in ppm) induced by

the ligand on uniformly 15N, 13C, 2H-labeled ppErk2 were calculated from the amide 1H (Δ δ H) and 15N
(Δ δ N) chemical shift changes using:

Δδ =

Δδ H 2 + (0.154Δδ N )2

(1 )

To determine substantially perturbed resonances, the following protocol derived from Schumann
was used27. A subset of resonances with CSPs within the average plus 3-times the standard deviation (σ )
was obtained through an iterative protocol where perturbations above this threshold were progressively
excluded until convergence to determine the average CSP and σ values. Values above the 1σ , 1.5σ ,
2σ and 3σ thresholds of the converged average were chosen to represent the degree of perturbation.
Intensity ratios between corresponding resonances in the titration series were determined using normalized intensities, with the normalization factor for each spectrum defined as the average intensity
calculated over a subgroup of intensities using the same protocol as the CSPs.
For uniformly 15N, 13C-labeled Elk387-399, the perturbations in the presence of ppERK2 were calculated
using the following equation (expressed as a %):

 δ 0,H − δ i,H
δ 0,het − δ i,het
∆i,sc = 100 
+
 2σ BMRB,H
2σ BMRB,het






(2)

δ 0,H and δ i,H are the chemical shifts for a particular 1H position (HN, Hα , Hε etc.) in free Elk387-399 and
that at the ith titration point; δ 0,het and δ i,het are the corresponding hetero-atom shifts (N, Cα , Cε etc.);
σ BMRB,H and σ BMRB,het are the corresponding positional standard-deviations from the BMRB.

Analysis of binding of Elk387-399 to the ppERK2 DRS. The affinity of Elk387-399 to the ppERK2 DRS
was obtained by fitting the CSPs of the significantly perturbed DRS resonances with increasing concentrations of Elk387-399 (CElk =  49, 73, 96, 124, 178, 458, 730, 994 μ M; the concentration of ppERK2,
CppERK2 =  93 μ M) to a two-site model using the following equations55:
Δδ = Δδsat

CElk,free
KD,DRS + CElk,free

a
θ 
2
+
(a 2 − 3b) cos 
 3 
3
3
+ KD,DRS + 2C ppErk 2 − CElk

CElk,free = −
a = KD,FRS

b = KD,FRSKD,DRS + (KD,FRS + KD,DRS )C ppErk 2 − (KD,FRS + KD,DRS )CElk
c = − KD,FRSKD,DRSCElk


 − 2a 3 + 9ab − 27c 

θ = cos−1
 2 (a 2 − 3b)3 



(3)

KD,FRS was held constant at 8 μ M (from the ITC measurements). Δ δ and Δ δ sat are the CSPs for the DRS
residues in at a given CElk and at saturation, respectively. At first, each resonance was fitted individually
for Δ δ and KD,DRS values. This was followed by a simultaneous fit of all datasets using a global KD,DRS (the
Φ chg residue D319 shows a complex behavior and was excluded from the global fit which used data from
residues T108, L113, T116, H118, S120, D122, T158 and C159). The statistical significance of the global
fit was assessed using the Akaike Information Criterion. These, and all other curve fitting described here
were carried out using the GraphPad Prism 6 software suite.

Relaxation measurements.

N spin-spin relaxation times (T2) were measured on 200 μ M uniformly
H, C, N-labeled ppERK2 containing 2 mM Elk387-399 in a buffer of the following composition: 20 mM
MES pH 6.4, 150 mM NaCl, 2 mM DTT and 200 μ M EDTA. Data were collected at 25 °C and 600 MHz
using the following relaxation delays: 0, 8.23 (2), 16.46, 24.69, 32.96 and 41.15 ms. 15 and 43 ppm spectral
windows with 512 and 80 complex points was used in the 1H and 15N dimension, respectively with a 3 s
recycle delay and 64 transients per increment.

2

13

15

15
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15
N spin-spin relaxation times (T2) were measured at 25 °C at 600 MHz on a 190 μ M uniformly 15N,
C-labeled Elk387-399 in the presence of 130 μ M active ppERK2 and 140 μ M KIM15-31, 5 mM MgCl2,
400 μ M AMPPCP in a buffer containing 20 mM MES pH 6.0, 150 mM NaCl, 500 μ M EDTA and 10 mM
DTT. Spectral windows of 15 and 10 ppm with 512 and 32 complex points in the 1H and 15N dimension,
respectively, with a 3 s recycle delay and 32 transients. The following relaxation delays were used: 10, 30,
70 (2), 110, 150, 210, 270, 350 ms. 15N RC-CPMG33 experiments (25 °C at 600 MHz) were also performed
on this sample using a constant delay TCPMG =  40 ms with spectral windows of 12 and 26 ppm spectral
window with 512 and 24 complex points in the 1H and 15N dimensions, respectively. A 2 s recycle delay
with 40 transients per increment and the following RF fields (ν 1): 0, 50, 100, 200, 300, 500, 700, 900,
1000 Hz, were used. The CPMG data were fit to a fast two-state exchange equation (Equation 4) to obtain
the exchange rate constant (kex, see below) first individually and then globally. The statistical significance
of the global fit was assessed using the Akaike Information Criterion.
13


 k 
4ν
R 2,eff (ν1) = R 2,eff (∞) + φ ex 1 − 1 tanh  ex  

 4ν1  
k ex

(4 )

2p (1 − p A ) Δω 2
and φ ex = A
k ex
The effective relaxation rate for a particular radiofrequency field (ν 1) is given
I (ν )
1
R 2,eff (ν1) = − T
ln I 1 where I(ν 1) and I0 are the peak intensities at the start and end of the relaxCPMG

0

ation delay (TCPMG), respectively. Δ ω represents the transient chemical shift difference; pA is the population of the major state.
Finally 15N relaxation spin-spin relaxation rates were also collected on 130 μ M Elk387-399 sample under
identical conditions as above except in the absence of ppERK2 using the following relaxation delays: 10.0,
70.0, 170, 270.0 (2), 430.0, 590, 790 ms.

Measurements of exchange transferred NOEs. Samples of the Elk387-399•ppERK2 complex for
NOESY experiments were prepared by dissolving uniformly 15N, 13C-labeled Elk387-399 peptide (750 μ M)
and unlabeled ppERK2 (33 μ M) in a buffer containing 50 mM phosphate pH 6.5, 150 mM NaCl and
0.5 mM EDTA. Amide and aliphatic exchange transfer NOEs (trNOE) were measured using 15N-edited
(16 transients collected for 400, 100 and 24 complex increments over sweep widths of 10 ppm, 10 ppm
and 20 ppm in the 1H dimensions and 15N dimension respectively) and 13C-edited (8 transients; 1024,
50 and 32 complex increments over sweep widths of 10 ppm, 10 ppm and 53 ppm in the 1H dimensions
and 13C dimension respectively) 3D-NOESY-HSQC experiments with mixing times of 150 ms and recycle delays of 1.5 s. The NOESY experiment on the free Elk387-399 peptide was carried out under the same
conditions as control.
Determination of the structure of Elk387-399 bound to ppERK2. To obtain an initial structural
ensemble of Elk387-399 bound to ppERK2, trNOEs determined above were used in a Cartesian dynamics
simulated annealing protocol using the Aria suite38. This consisted of: (1) 10000 steps of dynamics at
2000 K followed by 8000 steps of refinement; (2) 12000 steps of Cartesian dynamics while cooling from
2000 to 1000 K and then (3) 10000 steps of a second Cartesian dynamics cooling stage from 1000 to
50 K. Force constants of 10, 10 and 50 kCal mol−1 Å−2 were used for the unambiguous distance constraints during the three temperature stages of the Cartesian dynamics protocol. Prochiral Hβ and Hγ
for long-chain amino acids and methyl groups from valine and leucine were treated using the floating
chirality method. In all, 1024 structures were calculated of which 40 lowest energy structures (backbone RMSDs from the mean of 2.86 ±  0.71 Å) without violations were chosen to represent the structural
ensemble for input into the docking protocol.
In order to perform flexible docking of the Elk387-399 structural ensemble onto ppERK2, only the
K392’-S399’ fragment (trElk387-399) that was deemed to be rigid upon interaction with ppERK2 was used
in a HADDOCK-based docking protocol based on that described by Trellet56. An acetyl group was
inserted at the N-terminus of the fragment to mimic the A391’-K392’ peptide bond and to avoid the
introduction of an unnatural N-terminal amine. The crystal structure of ppERK2 (PDB ID: 2ERK)37
and five low-energy capped trElk387-399 structures representative of the ensemble were used as starting
configurations. Intermolecular (ambiguous) restraints were based on spectral perturbations and mutation data (see Results section) and intramolecular restrains constituted of the distances obtained from
the trNOE experiments. For each of the five initial trElk387-399 conformations, 4000 docked models were
created through a rigid body minimization protocol for a total of 20000 complexes, then the top scoring
600 structures underwent a semi-flexible simulated annealing protocol consisting of the following steps:
(1) 2000 steps (2 fs) of rigid body dynamics at 2000 K and 2000 cooling steps to 500 K; (2) 4000 steps
of a semi-flexible simulated annealing protocol in torsion angle space starting at 500 K and ending at
50 K, where the side chains at the protein/peptide interface were allowed to move; (3) finally 4000 steps
of semi-flexible simulated annealing starting at 500 K and ending at 50 K where both backbone and
sidechains at the complex interface were allowed to move. During these three stages all trElk387-399 and
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ppERK2 atoms belonging to the activation-loop residues D173 through R189 were fully flexible. The
interface was defined as those atoms from the two species within 5 Å of each other. Finally, all the resulting structures underwent refinement in explicit solvent consisting of 100 heating steps at 100 K, 200 K
and 300 K followed by 1250 sampling steps at 300 K and 2000 cooling steps at 300 K, 200 K and 100 K.

Kinase assays. Kinase assays to determine the Michelis-Menten parameters for the phosphorylation
of Elk387-399 by ppERK2 were performed in 100 μ L volumes at 30 °C in a buffer containing 25 mM HEPES
pH 7.5, 50 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 2 mM DTT, 10 mM MgCl2, and 40 μ g/mL BSA.
Reaction mixtures contained 2 nM ppERK2, and 1.6–400 μ M Elk387-399. The reaction mixture was incubated for 10 minutes at 30 °C before initiation with 500 μ M γ -32P ATP (specific activity of 1 ×  1015 cpm/
mol). Aliquots (10 μ L) were spotted onto P81 filter papers at fixed times. The filter papers were washed
three times for 15 minutes with 50 mM phosphoric acid to remove excess ATP and washed once with
acetone for drying. The amount of phosphate incorporated into Elk387-399 was determined by the associated counts per minute on a scintillation counter (Packard 1500) at a σ value of 2.
Fluorescence-based kinase assays were performed at 28 °C in a buffer containing 25 mM HEPES, pH
7.5, 50 mM KCl, 2 mM DTT, 0.1 mM EDTA, 0.1 mM EGTA, 0.5% glycerol, 2.5 mg/mL BSA, 10 mM MgCl2,
2 nM ppERK2 with various concentrations of the ERK-sensor-D1 peptide in the absence or the presence
of 100 μ M Elk387-399. The ERK-sensor-D1 peptide57 (QRKTLQRRNLKGLNLNL-X3-TGPLSPC-Sox-PF)
is a highly efficient ERK2 substrate and includes – (1) a D-site sequence (bold) derived from the yeast
MAP kinase kinase (MKK) Ste7, (2) a phosphorylatable serine (bold italics) fused to the C-terminus
using a flexible linker (X =  6-aminohexanoic acid) and (3) the cysteine at the + 2 position modified by a
sulfonamido-oxine (Sox) group. The reaction was initiated after 1 hour of pre-incubation at room temperature by adding 10 μ L of 5 mM Mg2+/ATP to 90 μ L of assay mixture and the fluorescence intensity
was recorded at each time point for a total of 6 minutes on a Fluorolog fluorimeter (Horiba Jobin Yvon) in
quartz cuvettes (Starna Cells) with a 10 mm path length and a reaction volume of 100 μ L. The sample was
excited at 360 nm and fluorescence was monitored at 492 nm using excitation and emission slit widths
of 3 nm. The change in fluorescence was related to the progression of the reaction using a previously
determined conversion factor58.
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